Shopping Cart
- Remove All
- Your shopping cart is currently empty
Perflubron (Perfluorooctyl bromide) can be emulsified with egg phospholipids (EYP) and displays exceptionally fast excretion characteristics. Perflubron(1-Bromoheptadecafluorooctane; Heptadecafluorooctyl bromide; Perfluorooctyl bromide) is a contrast medium for magnetic resonance imaging and sonography.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 mg | $29 | In Stock | |
500 mg | $64 | In Stock | |
1 g | $94 | In Stock | |
1 mL x 10 mM (in DMSO) | $29 | In Stock |
Description | Perflubron (Perfluorooctyl bromide) can be emulsified with egg phospholipids (EYP) and displays exceptionally fast excretion characteristics. Perflubron(1-Bromoheptadecafluorooctane; Heptadecafluorooctyl bromide; Perfluorooctyl bromide) is a contrast medium for magnetic resonance imaging and sonography. |
Animal Research | I. Magnetic Resonance Imaging (MRI) Application 1. Material Preparation: 1) Perflubron Emulsion: Perflubron is mixed with phosphatidylcholine (EYP) to form a stable emulsion. The concentration of Perflubron in the emulsion is usually 10%-40%. 2) Phosphatidylcholine (EYP): A lipid used to emulsify Perflubron, enhancing its solubility and stability in the aqueous phase. 3) MRI Equipment: Magnetic resonance imaging equipment equipped with high-resolution imaging capabilities. 2. Steps: 1) Preparation: Perflubron is mixed with EYP in a sterile environment to form a stable emulsion, and the concentration is adjusted according to imaging needs. 2) Injection: The emulsion is administered to the patient by intravenous injection, and an MRI scan is performed after the injection. 3) MRI Imaging: An MRI scan is performed and the distribution of the contrast agent is monitored. Perflubron can enhance tissue contrast, especially when monitoring vascular flow or assessing blood volume. 4) After imaging: Perflubron is usually excreted quickly through the lungs, which helps reduce the patient's exposure to contrast agents. 2. Ultrasound examination application 1. Material preparation: 1) Perflubron emulsion: As with magnetic resonance imaging, Perflubron emulsion is emulsified with lecithin to form a microbubble solution suitable for ultrasound imaging. 2) Ultrasound equipment: High-frequency ultrasound equipment that can detect microbubble signals. 2. Steps: 1) Preparation and injection: Prepare Perflubron microbubble emulsion and perform ultrasound examination after intravenous injection. 2) Imaging: Use ultrasound equipment to image blood vessels and tissue structures. Perflubron microbubbles can significantly improve the clarity of blood vessels and tissue boundaries. 3) After imaging: Microbubbles are usually excreted through the lungs, providing a fast, non-invasive imaging method. Precautions: 1) Dosage: The dose should be reasonably selected according to the imaging procedure and the specific situation of the patient to avoid excessive doses that lead to unnecessary exposure. 2) Patient safety: As with all contrast agents, there is a risk of allergic reactions. Patients should be monitored during and after the injection to detect adverse reactions. 3) Excretion monitoring: Although Perflubron is excreted rapidly, its excretion through the lungs must be monitored to avoid respiratory problems. |
Alias | PFOB, Perfluorooctyl bromide |
Molecular Weight | 498.96 |
Formula | C8BrF17 |
Cas No. | 423-55-2 |
Smiles | FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br |
Relative Density. | 1.93 g/cm3 at 25℃ (lit.) |
Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (100.21 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.